Company Filing History:
Years Active: 2012-2021
Title: Bolin Qin: Innovator in Cancer Treatment
Introduction
Bolin Qin is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 8 patents, Qin's work focuses on methods and compositions that inhibit the expression of PD-L1 in tumor cells.
Latest Patents
One of his latest patents involves processes for decreasing the expression of a CD274 gene and/or a PD-L1 protein in subjects. This patent outlines the administration of a composition containing at least 0.5% of an active ingredient by weight, which includes cinnamtannin D1 and/or cinnamtannin B1. Another notable patent addresses the inhibition of PD-L1 expression while enhancing PD-1 expression. This process is aimed at treating autoimmune diseases by modulating gene expression levels in subjects.
Career Highlights
Bolin Qin has worked with several companies, including Ingredients, Inc. and FHG Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.
Collaborations
Throughout his career, Qin has collaborated with notable professionals such as Augustin T. Romero and Peter J. Miller. These collaborations have further enriched his research and development efforts.
Conclusion
Bolin Qin's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for new therapeutic approaches.